Multiple sclerosis (MS) is a chronic autoimmune disease in the central nervous system (CNS) marked by inflammation, demyelination, and axonal loss. Currently available MS medication is limited, thereby calling for a strategy to accelerate new drug discovery. One of the strategies to discover new drugs is to utilize old drugs for new indications, an approach known as drug repurposing. Herein, we first identified 421 MS-associated SNPs from the Genome-Wide Association Study (GWAS) catalog (p-value < 5 × 10−8), and a total of 427 risk genes associated with MS using HaploReg version 4.1 under the criterion r2 > 0.8. MS risk genes were then prioritized using bioinformatics analysis to identify biological MS risk genes. The prioritization was performed based on six defined categories of functional annotations, namely missense mutation, cis-expression quantitative trait locus (cis-eQTL), molecular pathway analysis, protein-protein interaction (PPI), genes overlap with knockout mouse phenotype, and primary immunodeficiency (PID). A total of 144 biological MS risk genes were found and mapped into 194 genes within an expanded PPI network. According to the DrugBank and the Therapeutic Target Database, 27 genes within the list targeted by 68 new candidate drugs were identified. Importantly, the power of our approach is confirmed with the identification of a known approved drug (dimethyl fumarate) for MS. Based on additional data from ClinicalTrials.gov, eight drugs targeting eight distinct genes are prioritized with clinical evidence for MS disease treatment. Notably, CD80 and CD86 pathways are promising targets for MS drug repurposing. Using in silico drug repurposing, we identified belatacept as a promising MS drug candidate. Overall, this study emphasized the integration of functional genomic variants and bioinformatic-based approach that reveal important biological insights for MS and drive drug repurposing efforts for the treatment of this devastating disease.
21 November 2023 in Journal of Biomedicine and Translational Research
Background: Histopathological examination is critical to evaluate tissue condition. An accurate assessment is necessary for diagnosis establishment. Nowadays, both quantitative and qualitative scoring are enhanced with computer-assisted image analysis to reduce bias. Various software was developed to assist in image analysis. The question of whether the measurement results from one software will be comparable to those from another software may come up, given the wide variety of software options. Nevertheless, this subject is only occasionally discussed.Objective: This study aimed to compare the measurement results from Fiji and QuPath software in kidney histomorphometry.Methods: Normal kidney histological slide was observed. Selected histological structures, including the renal corpuscle area, glomerular area, Bowman space area, inner diameter of proximal, distal, and Henle loop, were measured using QuPath and Fiji software. The measurement results from the two software were compared for value differences and agreement analysis.Results: The renal corpuscle means the area was 12.7x103 µm2 in QuPath and 12.5 x103 µm2 in Fiji. The glomerular area was 7.8 x103 µm2 for both software. The proximal tubule's inner diameters varied from 18.7 to 150.8 µm. Smaller inner diameters were observed in distal tubules (17.1-80.5 µm) and The Henle loop (15.5-69.6 µm). There was no significant difference in measurement results of particular structures between the compared software (P-value > 0.05). The further confirmational analysis supported the similarity between the two measurement results.Conclusion: the measurement result of kidney microstructures using QuPath and Fiji were identical.
INTRODUCTION: Male aging may disrupt spermatogenesis and induce intratesticular redox imbalance, leading to testicular damage. Muntingia calabura leaf extracts (MCE) have potent antioxidant activity, but in vivo reports in the male reproductive system aging are limited. This research aimed to determine the effects of MCE on testicular histology and testosterone levels in the D-galactose-induced aging mice model. MATERIALS AND METHODS: Plasma and testicular tissue obtained from 20 male Mus musculus strain Balb/C which were divided into 5 groups: normal; aging; aging+ Muntingia calabura leaf aqueous extracts (MCE) 35 mg/kg; aging+MCE 70 mg/kg; and aging+vitamin C 28 mg/kg. Treatments were scheduled orally for 4 weeks; aging condition was induced using oral 500 mg/kg D-galactose for 6 weeks before treatments. Plasma testosterone was determined using ELISA, seminiferous tubules’ diameter, spermatogenesis score, and Leydig cell number were examined with routine staining, and the nuclear expression of Ki-67 was performed via immunohistochemistry. RESULTS: The MCE-treated aging group had higher seminiferous tubules’ diameter, spermatogenesis score, Leydig cells’ number, and percentage of cells expressing Ki-67 compared with the untreated group (p < 0.005), and the optimum dose was 70 mg/kg. However, testosterone levels of the MCE group did not significantly differ from those of others. CONCLUSION: Administration of MCE in D-galactose-induced aged mice improved seminiferous tubule diameter, spermatogenesis score, Leydig cells’ count, and spermatogenic cell proliferation, but not testosterone level.